At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy

Clinical Review for Basic Researchers: Treating patients with CTLA‐4 and PD‐1 pathway blocking antibodies, plus clinical progress and application of agents in earlier stages of development. It is increasingly appreciated that cancers are recognized by the immune system, and under some circumstances,...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of leukocyte biology Ročník 94; číslo 1; s. 41 - 53
Hlavní autori:	Callahan, Margaret K., Wolchok, Jedd D.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Society for Leukocyte Biology 01.07.2013
Predmet:	Antibodies, Blocking - therapeutic use Clinical Trials as Topic CTLA-4 Antigen - antagonists & inhibitors CTLA-4 Antigen - immunology endpoints Humans Immunotherapy Neoplasms - immunology Neoplasms - therapy overall survival Paired Basic-Translational Reviews Programmed Cell Death 1 Receptor - antagonists & inhibitors Programmed Cell Death 1 Receptor - immunology tumor overall survival endpoints tumor
ISSN:	0741-5400, 1938-3673, 1938-3673
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!